TY - JOUR AU - Kalia, L. V. AU - Lang, A. E. PY - 2015 DA - 2015// TI - Parkinson's disease JO - Lancet VL - 386 UR - https://doi.org/10.1016/S0140-6736(14)61393-3 DO - 10.1016/S0140-6736(14)61393-3 ID - Kalia2015 ER - TY - JOUR AU - Tokuda, T. AU - Qureshi, M. M. AU - Ardah, M. T. PY - 2010 DA - 2010// TI - Detection of elevated levels of alpha-synuclein oligomers in CSF from patients with Parkinson disease JO - Neurology VL - 75 UR - https://doi.org/10.1212/WNL.0b013e3181fd613b DO - 10.1212/WNL.0b013e3181fd613b ID - Tokuda2010 ER - TY - JOUR AU - Parnetti, L. AU - Cicognola, C. AU - Eusebi, P. AU - Chiasserini, D. PY - 2016 DA - 2016// TI - Value of cerebrospinal fluid alpha-synuclein species as biomarker in Parkinson's diagnosis and prognosis JO - Biomark Med VL - 10 UR - https://doi.org/10.2217/bmm.15.107 DO - 10.2217/bmm.15.107 ID - Parnetti2016 ER - TY - JOUR AU - Simonsen, A. H. AU - Kuiperij, B. AU - El-Agnaf, O. M. PY - 2016 DA - 2016// TI - The utility of alpha-synuclein as biofluid marker in neurodegenerative diseases: a systematic review of the literature JO - Biomark Med VL - 10 UR - https://doi.org/10.2217/BMM.14.105 DO - 10.2217/BMM.14.105 ID - Simonsen2016 ER - TY - JOUR AU - Gao, L. AU - Tang, H. AU - Nie, K. PY - 2015 DA - 2015// TI - Cerebrospinal fluid alpha-synuclein as a biomarker for Parkinson's disease diagnosis: a systematic review and meta-analysis JO - Int J Neurosci VL - 125 UR - https://doi.org/10.3109/00207454.2014.961454 DO - 10.3109/00207454.2014.961454 ID - Gao2015 ER - TY - JOUR AU - Eusebi, P. AU - Giannandrea, D. AU - Biscetti, L. PY - 2017 DA - 2017// TI - Diagnostic utility of cerebrospinal fluid alpha-synuclein in Parkinson's disease: a systematic review and meta-analysis JO - Mov Disord VL - 32 UR - https://doi.org/10.1002/mds.27110 DO - 10.1002/mds.27110 ID - Eusebi2017 ER - TY - JOUR AU - Tinsley, R. B. AU - Kotschet, K. AU - Modesto, D. PY - 2010 DA - 2010// TI - Sensitive and specific detection of alpha-synuclein in human plasma JO - J Neurosci Res VL - 88 ID - Tinsley2010 ER - TY - JOUR AU - Besong-Agbo, D. AU - Wolf, E. AU - Jessen, F. PY - 2013 DA - 2013// TI - Naturally occurring alpha-synuclein autoantibody levels are lower in patients with Parkinson disease JO - Neurology VL - 80 UR - https://doi.org/10.1212/WNL.0b013e31827b90d1 DO - 10.1212/WNL.0b013e31827b90d1 ID - Besong-Agbo2013 ER - TY - JOUR AU - Smith, L. M. AU - Schiess, M. C. AU - Coffey, M. P. AU - Klaver, A. C. AU - Loeffler, D. A. PY - 2012 DA - 2012// TI - Alpha-Synuclein and anti-alpha-synuclein antibodies in Parkinson's disease, atypical Parkinson syndromes, REM sleep behavior disorder, and healthy controls JO - PLoS One VL - 7 UR - https://doi.org/10.1371/journal.pone.0052285 DO - 10.1371/journal.pone.0052285 ID - Smith2012 ER - TY - JOUR AU - Duran, R. AU - Barrero, F. J. AU - Morales, B. AU - Luna, J. D. AU - Ramirez, M. AU - Vives, F. PY - 2010 DA - 2010// TI - Plasma alpha-synuclein in patients with Parkinson's disease with and without treatment JO - Mov Disord VL - 25 UR - https://doi.org/10.1002/mds.22928 DO - 10.1002/mds.22928 ID - Duran2010 ER - TY - JOUR AU - Lee, P. H. AU - Lee, G. AU - Park, H. J. AU - Bang, O. Y. AU - Joo, I. S. AU - Huh, K. PY - 2006 DA - 2006// TI - The plasma alpha-synuclein levels in patients with Parkinson's disease and multiple system atrophy JO - J Neural Transm (Vienna, Austria : 1996) VL - 113 UR - https://doi.org/10.1007/s00702-005-0427-9 DO - 10.1007/s00702-005-0427-9 ID - Lee2006 ER - TY - JOUR AU - Li, Q. X. AU - Mok, S. S. AU - Laughton, K. M. PY - 2007 DA - 2007// TI - Plasma alpha-synuclein is decreased in subjects with Parkinson's disease JO - Exp Neurol VL - 204 UR - https://doi.org/10.1016/j.expneurol.2006.12.006 DO - 10.1016/j.expneurol.2006.12.006 ID - Li2007 ER - TY - JOUR AU - Barbour, R. AU - Kling, K. AU - Anderson, J. P. PY - 2008 DA - 2008// TI - Red blood cells are the major source of alpha-synuclein in blood JO - Neurodegener Dis VL - 5 UR - https://doi.org/10.1159/000112832 DO - 10.1159/000112832 ID - Barbour2008 ER - TY - JOUR AU - Chahine, L. M. AU - Stern, M. B. AU - Chen-Plotkin, A. PY - 2014 DA - 2014// TI - Blood-based biomarkers for Parkinson's disease JO - Parkinsonism Relat Disord VL - 20 UR - https://doi.org/10.1016/S1353-8020(13)70025-7 DO - 10.1016/S1353-8020(13)70025-7 ID - Chahine2014 ER - TY - JOUR AU - Narayanan, V. AU - Scarlata, S. PY - 2001 DA - 2001// TI - Membrane binding and self-association of alpha-synucleins JO - Biochemistry VL - 40 UR - https://doi.org/10.1021/bi002952n DO - 10.1021/bi002952n ID - Narayanan2001 ER - TY - JOUR AU - Tosatto, L. AU - Andrighetti, A. O. AU - Plotegher, N. PY - 2012 DA - 2012// TI - Alpha-synuclein pore forming activity upon membrane association JO - Biochim Biophys Acta VL - 1818 UR - https://doi.org/10.1016/j.bbamem.2012.07.007 DO - 10.1016/j.bbamem.2012.07.007 ID - Tosatto2012 ER - TY - JOUR AU - Auluck, P. K. AU - Caraveo, G. AU - Lindquist, S. PY - 2010 DA - 2010// TI - Alpha-Synuclein: membrane interactions and toxicity in Parkinson's disease JO - Annu Rev Cell Dev Biol VL - 26 UR - https://doi.org/10.1146/annurev.cellbio.042308.113313 DO - 10.1146/annurev.cellbio.042308.113313 ID - Auluck2010 ER - TY - JOUR AU - Pretorius, E. AU - Swanepoel, A. C. AU - Buys, A. V. AU - Vermeulen, N. AU - Duim, W. AU - Kell, D. B. PY - 2014 DA - 2014// TI - Eryptosis as a marker of Parkinson's disease JO - Aging VL - 6 UR - https://doi.org/10.18632/aging.100695 DO - 10.18632/aging.100695 ID - Pretorius2014 ER - TY - JOUR AU - Reynolds, N. P. AU - Soragni, A. AU - Rabe, M. PY - 2011 DA - 2011// TI - Mechanism of membrane interaction and disruption by alpha-synuclein JO - J Am Chem Soc VL - 133 UR - https://doi.org/10.1021/ja2029848 DO - 10.1021/ja2029848 ID - Reynolds2011 ER - TY - JOUR AU - Jain, N. AU - Bhasne, K. AU - Hemaswasthi, M. AU - Mukhopadhyay, S. PY - 2013 DA - 2013// TI - Structural and dynamical insights into the membrane-bound alpha-synuclein JO - PLoS One VL - 8 UR - https://doi.org/10.1371/journal.pone.0083752 DO - 10.1371/journal.pone.0083752 ID - Jain2013 ER - TY - JOUR AU - El-Agnaf, O. M. AU - Salem, S. A. AU - Paleologou, K. E. PY - 2006 DA - 2006// TI - Detection of oligomeric forms of alpha-synuclein protein in human plasma as a potential biomarker for Parkinson's disease JO - FASEB J VL - 20 UR - https://doi.org/10.1096/fj.03-1449com DO - 10.1096/fj.03-1449com ID - El-Agnaf2006 ER - TY - JOUR AU - Foulds, P. G. AU - Mitchell, J. D. AU - Parker, A. PY - 2011 DA - 2011// TI - Phosphorylated alpha-synuclein can be detected in blood plasma and is potentially a useful biomarker for Parkinson's disease JO - FASEB J VL - 25 UR - https://doi.org/10.1096/fj.10-179192 DO - 10.1096/fj.10-179192 ID - Foulds2011 ER - TY - JOUR AU - Chen, L. AU - Feany, M. B. PY - 2005 DA - 2005// TI - Alpha-synuclein phosphorylation controls neurotoxicity and inclusion formation in a Drosophila model of Parkinson disease JO - Nat Neurosci VL - 8 UR - https://doi.org/10.1038/nn1443 DO - 10.1038/nn1443 ID - Chen2005 ER - TY - JOUR AU - Gorbatyuk, O. S. AU - Li, S. AU - Sullivan, L. F. PY - 2008 DA - 2008// TI - The phosphorylation state of Ser-129 in human alpha-synuclein determines neurodegeneration in a rat model of Parkinson disease JO - Proc Natl Acad Sci U S A VL - 105 UR - https://doi.org/10.1073/pnas.0711053105 DO - 10.1073/pnas.0711053105 ID - Gorbatyuk2008 ER - TY - JOUR AU - Kragh, C. L. AU - Lund, L. B. AU - Febbraro, F. PY - 2009 DA - 2009// TI - Alpha-synuclein aggregation and Ser-129 phosphorylation-dependent cell death in oligodendroglial cells JO - J Biol Chem VL - 284 UR - https://doi.org/10.1074/jbc.M809671200 DO - 10.1074/jbc.M809671200 ID - Kragh2009 ER - TY - JOUR AU - Roberts, H. L. AU - Brown, D. R. PY - 2015 DA - 2015// TI - Seeking a mechanism for the toxicity of oligomeric alpha-synuclein JO - Biomolecules VL - 5 UR - https://doi.org/10.3390/biom5020282 DO - 10.3390/biom5020282 ID - Roberts2015 ER - TY - JOUR AU - Deas, E. AU - Cremades, N. AU - Angelova, P. R. PY - 2016 DA - 2016// TI - Alpha-Synuclein oligomers interact with metal ions to induce oxidative stress and neuronal death in Parkinson's disease JO - Antioxid Redox Signal VL - 24 UR - https://doi.org/10.1089/ars.2015.6343 DO - 10.1089/ars.2015.6343 ID - Deas2016 ER - TY - JOUR AU - Winner, B. AU - Jappelli, R. AU - Maji, S. K. PY - 2011 DA - 2011// TI - In vivo demonstration that alpha-synuclein oligomers are toxic JO - Proc Natl Acad Sci U S A VL - 108 UR - https://doi.org/10.1073/pnas.1100976108 DO - 10.1073/pnas.1100976108 ID - Winner2011 ER - TY - JOUR AU - Wang, X. AU - Yu, S. AU - Li, F. AU - Feng, T. PY - 2015 DA - 2015// TI - Detection of alpha-synuclein oligomers in red blood cells as a potential biomarker of Parkinson's disease JO - Neurosci Lett VL - 599 UR - https://doi.org/10.1016/j.neulet.2015.05.030 DO - 10.1016/j.neulet.2015.05.030 ID - Wang2015 ER - TY - JOUR AU - Zhao, H. Q. AU - Li, F. F. AU - Wang, Z. AU - Wang, X. M. AU - Feng, T. PY - 2016 DA - 2016// TI - A comparative study of the amount of alpha-synuclein in ischemic stroke and Parkinson's disease JO - Neurol Sci VL - 37 UR - https://doi.org/10.1007/s10072-016-2485-1 DO - 10.1007/s10072-016-2485-1 ID - Zhao2016 ER - TY - JOUR AU - Hughes, A. J. AU - Daniel, S. E. AU - Kilford, L. AU - Lees, A. J. PY - 1992 DA - 1992// TI - Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases JO - J Neurol Neurosurg Psychiatry VL - 55 UR - https://doi.org/10.1136/jnnp.55.3.181 DO - 10.1136/jnnp.55.3.181 ID - Hughes1992 ER - TY - JOUR AU - Hong, Z. AU - Shi, M. AU - Chung, K. A. PY - 2010 DA - 2010// TI - DJ-1 and alpha-synuclein in human cerebrospinal fluid as biomarkers of Parkinson's disease JO - Brain VL - 133 UR - https://doi.org/10.1093/brain/awq008 DO - 10.1093/brain/awq008 ID - Hong2010 ER - TY - JOUR AU - Stewart, T. AU - Sossi, V. AU - Aasly, J. O. PY - 2015 DA - 2015// TI - Phosphorylated alpha-synuclein in Parkinson's disease: correlation depends on disease severity JO - Acta Neuropathol Commun VL - 3 UR - https://doi.org/10.1186/s40478-015-0185-3 DO - 10.1186/s40478-015-0185-3 ID - Stewart2015 ER - TY - JOUR AU - Goetz, C. G. AU - Tilley, B. C. AU - Shaftman, S. R. PY - 2008 DA - 2008// TI - Movement Disorder Society-sponsored revision of the unified Parkinson's disease rating scale (MDS-UPDRS): scale presentation and clinimetric testing results JO - Mov Disord VL - 23 UR - https://doi.org/10.1002/mds.22340 DO - 10.1002/mds.22340 ID - Goetz2008 ER - TY - JOUR AU - Hoops, S. AU - Nazem, S. AU - Siderowf, A. D. PY - 2009 DA - 2009// TI - Validity of the MoCA and MMSE in the detection of MCI and dementia in Parkinson disease JO - Neurology VL - 73 UR - https://doi.org/10.1212/WNL.0b013e3181c34b47 DO - 10.1212/WNL.0b013e3181c34b47 ID - Hoops2009 ER - TY - JOUR AU - Stine, W. B. AU - Dahlgren, K. N. AU - Krafft, G. A. AU - LaDu, M. J. PY - 2003 DA - 2003// TI - In vitro characterization of conditions for amyloid-beta peptide oligomerization and fibrillogenesis JO - J Biol Chem VL - 278 UR - https://doi.org/10.1074/jbc.M210207200 DO - 10.1074/jbc.M210207200 ID - Stine2003 ER - TY - JOUR AU - Mollenhauer, B. AU - Cullen, V. AU - Kahn, I. PY - 2008 DA - 2008// TI - Direct quantification of CSF alpha-synuclein by ELISA and first cross-sectional study in patients with neurodegeneration JO - Exp Neurol VL - 213 UR - https://doi.org/10.1016/j.expneurol.2008.06.004 DO - 10.1016/j.expneurol.2008.06.004 ID - Mollenhauer2008 ER - TY - JOUR AU - Mollenhauer, B. AU - Trautmann, E. AU - Taylor, P. PY - 2013 DA - 2013// TI - Total CSF alpha-synuclein is lower in de novo Parkinson patients than in healthy subjects JO - Neurosci Lett VL - 532 UR - https://doi.org/10.1016/j.neulet.2012.11.004 DO - 10.1016/j.neulet.2012.11.004 ID - Mollenhauer2013 ER - TY - JOUR AU - Lassen, L. B. AU - Gregersen, E. AU - Isager, A. K. AU - Betzer, C. AU - Kofoed, R. H. AU - Jensen, P. H. PY - 2018 DA - 2018// TI - ELISA method to detect alpha-synuclein oligomers in cell and animal models JO - PLoS One VL - 13 UR - https://doi.org/10.1371/journal.pone.0196056 DO - 10.1371/journal.pone.0196056 ID - Lassen2018 ER - TY - JOUR AU - Spillantini, M. G. AU - Schmidt, M. L. AU - Lee, V. M. AU - Trojanowski, J. Q. AU - Jakes, R. AU - Goedert, M. PY - 1997 DA - 1997// TI - Alpha-synuclein in Lewy bodies JO - Nature VL - 388 UR - https://doi.org/10.1038/42166 DO - 10.1038/42166 ID - Spillantini1997 ER - TY - JOUR AU - Majbour, N. K. AU - Vaikath, N. N. AU - Dijk, K. D. PY - 2016 DA - 2016// TI - Oligomeric and phosphorylated alpha-synuclein as potential CSF biomarkers for Parkinson's disease JO - Mol Neurodegener VL - 11 UR - https://doi.org/10.1186/s13024-016-0072-9 DO - 10.1186/s13024-016-0072-9 ID - Majbour2016 ER - TY - JOUR AU - Papagiannakis, N. AU - Koros, C. AU - Stamelou, M. PY - 2018 DA - 2018// TI - Alpha-synuclein dimerization in erythrocytes of patients with genetic and non-genetic forms of Parkinson's disease JO - Neurosci Lett VL - 672 UR - https://doi.org/10.1016/j.neulet.2017.11.012 DO - 10.1016/j.neulet.2017.11.012 ID - Papagiannakis2018 ER - TY - JOUR AU - Vicente Miranda, H. AU - Cassio, R. AU - Correia-Guedes, L. PY - 2017 DA - 2017// TI - Posttranslational modifications of blood-derived alpha-synuclein as biochemical markers for Parkinson's disease JO - Sci Rep VL - 7 UR - https://doi.org/10.1038/s41598-017-14175-5 DO - 10.1038/s41598-017-14175-5 ID - Vicente Miranda2017 ER - TY - JOUR AU - Abd-Elhadi, S. AU - Honig, A. AU - Simhi-Haham, D. PY - 2015 DA - 2015// TI - Total and proteinase K-resistant alpha-Synuclein levels in erythrocytes, determined by their ability to bind phospholipids, associate with Parkinson's disease JO - Sci Rep VL - 5 UR - https://doi.org/10.1038/srep11120 DO - 10.1038/srep11120 ID - Abd-Elhadi2015 ER - TY - JOUR AU - Fabelo, N. AU - Martin, V. AU - Santpere, G. PY - 2011 DA - 2011// TI - Severe alterations in lipid composition of frontal cortex lipid rafts from Parkinson's disease and incidental Parkinson's disease JO - Mol Med VL - 17 UR - https://doi.org/10.2119/molmed.2011.00119 DO - 10.2119/molmed.2011.00119 ID - Fabelo2011 ER - TY - JOUR AU - Zhu, M. AU - Li, J. AU - Fink, A. L. PY - 2003 DA - 2003// TI - The association of alpha-synuclein with membranes affects bilayer structure, stability, and fibril formation JO - J Biol Chem VL - 278 UR - https://doi.org/10.1074/jbc.M305326200 DO - 10.1074/jbc.M305326200 ID - Zhu2003 ER - TY - JOUR AU - Grey, M. AU - Linse, S. AU - Nilsson, H. AU - Brundin, P. AU - Sparr, E. PY - 2011 DA - 2011// TI - Membrane interaction of alpha-synuclein in different aggregation states JO - J Park Dis VL - 1 ID - Grey2011 ER - TY - JOUR AU - Rekas, A. AU - Knott, R. B. AU - Sokolova, A. PY - 2010 DA - 2010// TI - The structure of dopamine induced alpha-synuclein oligomers JO - Eur Biophys J VL - 39 UR - https://doi.org/10.1007/s00249-010-0595-x DO - 10.1007/s00249-010-0595-x ID - Rekas2010 ER - TY - JOUR AU - Anderson, J. P. AU - Walker, D. E. AU - Goldstein, J. M. PY - 2006 DA - 2006// TI - Phosphorylation of Ser-129 is the dominant pathological modification of alpha-synuclein in familial and sporadic Lewy body disease JO - J Biol Chem VL - 281 UR - https://doi.org/10.1074/jbc.M600933200 DO - 10.1074/jbc.M600933200 ID - Anderson2006 ER - TY - JOUR AU - Fujiwara, H. AU - Hasegawa, M. AU - Dohmae, N. PY - 2002 DA - 2002// TI - Alpha-Synuclein is phosphorylated in synucleinopathy lesions JO - Nat Cell Biol VL - 4 UR - https://doi.org/10.1038/ncb748 DO - 10.1038/ncb748 ID - Fujiwara2002 ER - TY - JOUR AU - Walker, D. G. AU - Lue, L. F. AU - Adler, C. H. PY - 2013 DA - 2013// TI - Changes in properties of serine 129 phosphorylated alpha-synuclein with progression of Lewy-type histopathology in human brains JO - Exp Neurol VL - 240 UR - https://doi.org/10.1016/j.expneurol.2012.11.020 DO - 10.1016/j.expneurol.2012.11.020 ID - Walker2013 ER - TY - JOUR AU - Saito, Y. AU - Kawashima, A. AU - Ruberu, N. N. PY - 2003 DA - 2003// TI - Accumulation of phosphorylated alpha-synuclein in aging human brain JO - J Neuropathol Exp Neurol VL - 62 UR - https://doi.org/10.1093/jnen/62.6.644 DO - 10.1093/jnen/62.6.644 ID - Saito2003 ER - TY - JOUR AU - Oueslati, A. PY - 2016 DA - 2016// TI - Implication of alpha-Synuclein phosphorylation at S129 in Synucleinopathies: what have we learned in the last decade? JO - J Park Dis VL - 6 ID - Oueslati2016 ER - TY - JOUR AU - Zhou, J. AU - Broe, M. AU - Huang, Y. PY - 2011 DA - 2011// TI - Changes in the solubility and phosphorylation of alpha-synuclein over the course of Parkinson's disease JO - Acta Neuropathol VL - 121 UR - https://doi.org/10.1007/s00401-011-0815-1 DO - 10.1007/s00401-011-0815-1 ID - Zhou2011 ER - TY - JOUR AU - Wang, Y. AU - Shi, M. AU - Chung, K. A. PY - 2012 DA - 2012// TI - Phosphorylated alpha-synuclein in Parkinson's disease JO - Sci Transl Med VL - 4 ID - Wang2012 ER - TY - JOUR AU - Foulds, P. G. AU - Diggle, P. AU - Mitchell, J. D. PY - 2013 DA - 2013// TI - A longitudinal study on alpha-synuclein in blood plasma as a biomarker for Parkinson's disease JO - Sci Rep VL - 3 UR - https://doi.org/10.1038/srep02540 DO - 10.1038/srep02540 ID - Foulds2013 ER - TY - JOUR AU - Steenoven, I. AU - Majbour, N. K. AU - Vaikath, N. N. PY - 2018 DA - 2018// TI - Alpha-Synuclein species as potential cerebrospinal fluid biomarkers for dementia with lewy bodies JO - Mov Disord VL - 33 UR - https://doi.org/10.1002/mds.111 DO - 10.1002/mds.111 ID - Steenoven2018 ER - TY - JOUR AU - Daniele, S. AU - Frosini, D. AU - Pietrobono, D. PY - 2018 DA - 2018// TI - Alpha-Synuclein Heterocomplexes with beta-amyloid are increased in red blood cells of Parkinson's disease patients and correlate with disease severity JO - Front Mol Neurosci VL - 11 UR - https://doi.org/10.3389/fnmol.2018.00053 DO - 10.3389/fnmol.2018.00053 ID - Daniele2018 ER - TY - JOUR AU - Stewart, T. AU - Liu, C. AU - Ginghina, C. PY - 2014 DA - 2014// TI - Cerebrospinal fluid alpha-synuclein predicts cognitive decline in Parkinson disease progression in the DATATOP cohort JO - Am J Pathol VL - 184 UR - https://doi.org/10.1016/j.ajpath.2013.12.007 DO - 10.1016/j.ajpath.2013.12.007 ID - Stewart2014 ER - TY - JOUR AU - Kang, J. H. AU - Mollenhauer, B. AU - Coffey, C. S. PY - 2016 DA - 2016// TI - CSF biomarkers associated with disease heterogeneity in early Parkinson's disease: the Parkinson's progression markers initiative study JO - Acta Neuropathol VL - 131 UR - https://doi.org/10.1007/s00401-016-1552-2 DO - 10.1007/s00401-016-1552-2 ID - Kang2016 ER - TY - STD TI - Schirinzi T, Sancesario GM, Di Lazzaro G, et al. CSF alpha-synuclein inversely correlates with non-motor symptoms in a cohort of PD patients. Parkinsonism Relat Disord. 2018. ID - ref61 ER - TY - JOUR AU - George, S. AU - Rey, N. L. AU - Reichenbach, N. AU - Steiner, J. A. AU - Brundin, P. PY - 2013 DA - 2013// TI - Alpha-Synuclein: the long distance runner JO - Brain Pathol (Zurich, Switzerland) VL - 23 UR - https://doi.org/10.1111/bpa.12046 DO - 10.1111/bpa.12046 ID - George2013 ER - TY - JOUR AU - Emmanouilidou, E. AU - Melachroinou, K. AU - Roumeliotis, T. PY - 2010 DA - 2010// TI - Cell-produced alpha-synuclein is secreted in a calcium-dependent manner by exosomes and impacts neuronal survival JO - J Neurosci VL - 30 UR - https://doi.org/10.1523/JNEUROSCI.5699-09.2010 DO - 10.1523/JNEUROSCI.5699-09.2010 ID - Emmanouilidou2010 ER - TY - JOUR AU - Matsumoto, J. AU - Stewart, T. AU - Sheng, L. PY - 2017 DA - 2017// TI - Transmission of alpha-synuclein-containing erythrocyte-derived extracellular vesicles across the blood-brain barrier via adsorptive mediated transcytosis: another mechanism for initiation and progression of Parkinson's disease? JO - Acta Neuropathol Commun VL - 5 UR - https://doi.org/10.1186/s40478-017-0470-4 DO - 10.1186/s40478-017-0470-4 ID - Matsumoto2017 ER -